Cure My Disease

Don't miss your cure!

Home News About
Log in / Sign up
← Back to home

Enyo Pharma

Clinical trials sponsored by Enyo Pharma, explained in plain language.

Trials to join now! 1 Completed 1
Sort by
  • New drug tested to slow kidney damage in rare genetic disease

    Disease control Completed

    This study tested whether a drug called vonafexor is safe and can help protect kidney function in people with Alport syndrome, a genetic condition that damages the kidneys over time. It involved 26 patients who were at risk of their disease getting worse. Participants took the dr…

    Phase: PHASE2 • Sponsor: Enyo Pharma • Aim: Disease control

    Last updated Mar 16, 2026 15:24 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Terms of use Contact us

This is a site from Cyber and Space